IOLCP Q4 FY26 Guidance vs Delivery (IOLCP Management Mirror)

Did IOLCP's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • IOLCP Financials
  • IOLCP Shareholding Pattern
  • IOLCP Earnings Documents
  • IOLCP Announcements
  • IOLCP Corporate Actions
  • IOLCP Bulk, Block & Insider Deals
  • IOLCP Delivery Data
  • IOLCP Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

IOL Chemicals & Pharmaceuticals Ltd (IOLCP) Q4FY26 Management Mirror - Mar-2026 Qtr

Revenue Outlook

Management in the Mar'26 Qtr reaffirmed the Mar'27 revenue target of approximately 2,700 crore with a mid-to-high teen percentage growth expectation, perfectly consistent with the 2,600 crore to 2,700 crore target first introduced in the Sep'25 Qtr and structurally maintained through the Dec'25 Qtr. [Status: Reaffirmed]

4 more themes on the ELITE plan.

  • IOLCP Q4FY26 Concall Summary
  • IOLCP Q4FY26 Concall Transcript
  • IOLCP Q3FY26 Management Mirror (Dec-2025 Qtr)
  • IOLCP Q1FY27 Management Mirror (Jun-2026 Qtr)